Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic …

DL Grieco, LS Menga, M Cesarano, T Rosà, S Spadaro… - Jama, 2021 - jamanetwork.com
Importance High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic
respiratory failure and is widely applied in patients with COVID-19. Objective To assess …
被引用次数：434 相关文章

Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients with COVID-19 and Moderate to Severe …

DL Grieco, LS Menga, M Cesarano, T Rosa, S Spadaro… - JAMA, 2021 - sfera.unife.it
Importance: High-flow nasal oxygen is recommended as initial treatment for acute
hypoxemic respiratory failure and is widely applied in patients with COVID-19. Objective: To …

Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe …

DL Grieco, LS Menga, M Cesarano, T Rosà, S Spadaro… - 2021 - pubmed.ncbi.nlm.nih.gov
Importance High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic
respiratory failure and is widely applied in patients with COVID-19. Objective To assess …
[PDF] rumedo.ru

[PDF][PDF] Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe …

S Heart, F Lgo - JAMA, 2021 - rumedo.ru
OBJECTIVE To assess whether helmet noninvasive ventilation can increase the days free of
respiratory support in patients with COVID-19 compared with high-flow nasal oxygen alone …
[HTML] nih.gov

[HTML][HTML] Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe …

DL Grieco, LS Menga, M Cesarano, T Rosà, S Spadaro… - JAMA, 2021 - ncbi.nlm.nih.gov
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of
Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic …

Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe …

DL Grieco, LS Menga, M Cesarano, T Rosà, S Spadaro… - JAMA, 2021 - europepmc.org
Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of
Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory …

Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe …

DL Grieco, LS Menga, M Cesarano, T Rosà, S Spadaro… - JAMA, 2021 - ricerca.unich.it
Importance: High-flow nasal oxygen is recommended as initial treatment for acute
hypoxemic respiratory failure and is widely applied in patients with COVID-19. Objective: To …
[PDF] unife.it

[PDF][PDF] Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe …

S Heart, F Lgo - JAMA, 2021 - iris.unife.it
OBJECTIVE To assess whether helmet noninvasive ventilation can increase the days free of
respiratory support in patients with COVID-19 compared with high-flow nasal oxygen alone …

Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic …

DL Grieco, LS Menga, M Cesarano, T Rosà, S Spadaro… - 2021 - cabidigitallibrary.org
Importance: High-flow nasal oxygen is recommended as initial treatment for acute
hypoxemic respiratory failure and is widely applied in patients with COVID-19. Objective: To …

Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe …

DL Grieco, LS Menga, M Cesarano, T Rosà, S Spadaro… - JAMA, 2021 - cris.unibo.it
Importance: High-flow nasal oxygen is recommended as initial treatment for acute
hypoxemic respiratory failure and is widely applied in patients with COVID-19. Objective: To …